tiprankstipranks
Advertisement

BGIG - ETF AI Analysis

Compare

Top Page

BGIG

Bahl & Gaynor Income Growth ETF (BGIG)

Rating:73Outperform
Price Target:
BGIG’s rating suggests it is a solid, but not flawless, income and growth ETF, supported by high-quality leaders like Microsoft, TSMC, Broadcom, and Johnson & Johnson, which benefit from strong financial performance, positive earnings outlooks, and growth in areas like AI and healthcare. These strengths are partly offset by holdings such as AbbVie and Williams, where high leverage, cash flow concerns, and richer valuations introduce more risk. The main risk factor is the fund’s reliance on a concentrated group of large companies in sectors like technology and healthcare, where premium valuations could be vulnerable if growth expectations are not met.
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains over the past month, three months, and year-to-date, showing positive recent momentum.
Large and Growing Asset Base
With over two billion dollars in assets, the fund appears well-established and has attracted meaningful investor interest.
Sector Diversification Across the Economy
Holdings are spread across technology, financials, health care, energy, industrials, utilities, and consumer sectors, helping reduce the impact of weakness in any single industry.
Negative Factors
Heavy U.S. Concentration
Almost all of the fund’s assets are invested in U.S. companies, offering little geographic diversification if the U.S. market struggles.
Mixed Performance Among Top Holdings
While several large positions have shown strong gains, some other major holdings have been weak this year, which can create uneven performance.
Moderate Expense Ratio
The fund’s fee is not especially low for an ETF, which slightly reduces the net return investors keep over time.

BGIG vs. SPDR S&P 500 ETF (SPY)

BGIG Summary

The Bahl & Gaynor Income Growth ETF (BGIG) is an actively managed fund that focuses on large, established U.S. companies that pay dividends and have room to grow over time. It doesn’t track a specific index, but instead builds a broad mix across sectors like technology, health care, financials, and energy. Well-known holdings include Microsoft and Johnson & Johnson. Someone might invest in BGIG to seek a mix of regular income from dividends and long-term growth in one diversified fund. A key risk is that its stock holdings can go up and down with the overall market, and it is especially exposed to large U.S. companies.
How much will it cost me?The Bahl & Gaynor Income Growth ETF (BGIG) has an expense ratio of 0.45%, meaning you’ll pay $4.50 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, which typically involves more research and decision-making compared to passively managed funds. However, this cost reflects the expertise in selecting a curated portfolio of large-cap companies focused on income and growth.
What would affect this ETF?The BGIG ETF, with its focus on large-cap U.S. companies and sectors like technology, healthcare, and financials, could benefit from continued innovation in tech and stable demand for healthcare products. However, rising interest rates or economic slowdowns might negatively impact financial and consumer sectors, while regulatory changes in healthcare or technology could pose risks. Its emphasis on dividend-paying companies provides stability but may underperform during high-growth market cycles.

BGIG Top 10 Holdings

BGIG leans heavily on U.S. large caps, with a clear tilt toward tech and health care, and that mix is shaping returns. Broadcom and TSMC are doing much of the heavy lifting, riding the AI and chip boom, while UnitedHealth and Johnson & Johnson add steady, defensive strength from the health care side. Williams Co is quietly boosting results as energy stays in favor. On the flip side, Microsoft looks a bit tired lately, and NextEra Energy has been losing steam, modestly dragging on this otherwise income-focused, U.S.-centric portfolio.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Broadcom5.38%$114.36M$1.96T54.52%
76
Outperform
UnitedHealth4.74%$100.78M$364.13B35.25%
72
Outperform
Eli Lilly & Co4.13%$87.77M$1.03T43.01%
72
Outperform
TSMC3.98%$84.58M$1.97T122.36%
81
Outperform
PNC Financial3.94%$83.66M$93.18B29.85%
71
Outperform
Apollo Global Management3.76%$79.97M$79.27B0.88%
75
Outperform
Johnson & Johnson3.68%$78.13M$549.78B52.85%
78
Outperform
Microsoft3.50%$74.38M$2.82T-24.42%
79
Outperform
Williams Co3.26%$69.30M$89.43B23.92%
76
Outperform
AbbVie3.07%$65.26M$382.49B25.17%
66
Neutral

BGIG Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
34.87
Positive
100DMA
34.26
Positive
200DMA
33.10
Positive
Market Momentum
MACD
0.16
Positive
RSI
56.57
Neutral
STOCH
48.72
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BGIG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 35.30, equal to the 50-day MA of 34.87, and equal to the 200-day MA of 33.10, indicating a bullish trend. The MACD of 0.16 indicates Positive momentum. The RSI at 56.57 is Neutral, neither overbought nor oversold. The STOCH value of 48.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BGIG.

BGIG Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$2.12B0.45%
73
Outperform
$7.77B0.18%
74
Outperform
$7.21B0.56%
70
Outperform
$7.05B0.31%
71
Outperform
$4.68B0.29%
74
Outperform
$4.44B0.29%
73
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BGIG
Bahl & Gaynor Income Growth ETF
35.45
5.77
19.44%
FELC
Fidelity Enhanced Large Cap Core ETF
DIVO
Amplify CWP Enhanced Dividend Income ETF
TCAF
T. Rowe Price Capital Appreciation Equity ETF
GPIQ
Goldman Sachs Nasdaq 100 Core Premium Income ETF
GPIX
Goldman Sachs S&P 500 Core Premium Income ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement